Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Different Types of Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06805019
What this trial is testing

Construction of a Model for the Differential Diagnosis of SArcoma/myoma Based on the RAdiomics Features: Single-center Observational Study

Who this might be right for
Uterine SarcomaUterine Myoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 176
Testing effectiveness (Phase 2)Looking for participantsNCT07249905
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Who this might be right for
LymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more
ModeX Therapeutics, An OPKO Health Company 180
Not applicableStudy completedNCT04435964
What this trial is testing

Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

Who this might be right for
MelanomaLung CancerHead and Neck Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 247
Testing effectiveness (Phase 2)Study completedNCT00705016
What this trial is testing

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Cancer
Merck KGaA, Darmstadt, Germany 184
Not applicableUnknownNCT02288026
What this trial is testing

Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-small Cell Lung CancerAdenocarcinoma of the LungSquamous Cell Lung Cancer
Capital Medical University 630
Not applicableStudy completedNCT01570452
What this trial is testing

Matrilysin Expression in Different Stages of Colorectal Tumors

Who this might be right for
Colorectal Cancer Stage 0Colorectal Cancer Stage IColorectal Cancer Stage II+2 more
University of Roma La Sapienza 38
Not applicableUnknownNCT03777475
What this trial is testing

The Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 350
Not applicableUnknownNCT05779527
What this trial is testing

Mindful Parenting - A Single Case Experimental Design Study

Who this might be right for
ParentingAlopeciaSkin Condition+4 more
Cardiff University 12
Testing effectiveness (Phase 2)Ended earlyNCT00543582
What this trial is testing

MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaNon-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)
Mirati Therapeutics Inc. 23
Testing effectiveness (Phase 2)Study completedNCT02131662
What this trial is testing

Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap

Who this might be right for
Leiomyoma
Bayer 309
Large-scale testing (Phase 3)Study completedNCT02038296
What this trial is testing

Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Guangdong Provincial People's Hospital 162
Testing effectiveness (Phase 2)Study completedNCT00961896
What this trial is testing

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Novartis Pharmaceuticals 18
Early research (Phase 1)Study completedNCT04811196
What this trial is testing

Different Dosing Schedules of Selinexor in Sarcoma Patients

Who this might be right for
Soft Tissue SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Leiomyosarcoma+1 more
University Health Network, Toronto 56
Not applicableUnknownNCT04453956
What this trial is testing

A Single Center Study on Comparing the Different Function of EndoAngel in Improving the Quality of Colonscopy

Who this might be right for
Adenoma
Renmin Hospital of Wuhan University 1,090
Not applicableStudy completedNCT07066774
What this trial is testing

Biopsy Needle Size in Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma of the Limb
Ankara City Hospital Bilkent 30
Not applicableStudy completedNCT02023476
What this trial is testing

Neurologic Examination of Wide and Narrow Tourniquets

Who this might be right for
Nerve Compression
Medical University of Vienna 18
Testing effectiveness (Phase 2)Study completedNCT04316182
What this trial is testing

Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 24
Not applicableLooking for participantsNCT06767579
What this trial is testing

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Yonsei University 350
Not applicableStudy completedNCT03630978
What this trial is testing

Impact of Sarcopenia on Postoperative Outcomes of Patients Undergoing Liver Resection

Who this might be right for
Liver NeoplasmsSarcopeniaPostoperative Complications
San Camillo Hospital, Rome 251
Testing effectiveness (Phase 2)Study completedNCT03173560
What this trial is testing

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Eisai Inc. 343
Next Page